Gufic Biosciences (NSE:GUFICBIO) 3-Year EBITDA Growth Rate : 19.10% (As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Gufic Biosciences 3-Year EBITDA Growth Rate?

Gufic Biosciences's EBITDA per Share for the three months ended in Dec. 2024 was ₹3.58.

During the past 12 months, Gufic Biosciences's average EBITDA Per Share Growth Rate was -3.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 19.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 23.50% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 27.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Gufic Biosciences was 42.40% per year. The lowest was 4.30% per year. And the median was 24.15% per year.

Competitive Comparison of Gufic Biosciences's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Gufic Biosciences's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gufic Biosciences's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gufic Biosciences's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Gufic Biosciences's 3-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Gufic Biosciences 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Gufic Biosciences (NSE:GUFICBIO) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Gufic Biosciences 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Gufic Biosciences's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Gufic Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gufic Biosciences Ltd (NSE:GUFICBIO) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

509079:India

Address

SM House, 11 Sahakar Road, 1st to 4th Floor, Vile Parle (East), Mumbai, MH, IND, 400 057

Website

https://www.gufic.com

Gufic Biosciences Ltd is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Geographically, it derives a majority of revenue from India. Its product portfolio includes Criticare; Criticare Life; Ferticare; Spark; Herbal and other products. The company's lyophilized product includes antibiotics, anti-fungal, cardiac, infertility, anti-viral and a proton-pump inhibitor. It derives maximum revenue from India.

Gufic Biosciences Headlines

No Headlines